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Amino acid differences in glycoproteins B (gB), C
(gC), H (gH) and L(gL) are associated with enhanced
herpes simplex virus type-1 (McKrae) entry via the
paired immunoglobulin-like type-2 receptor a
Sona Chowdhury, Misagh Naderi, Vladimir N Chouljenko*, Jason D Walker and Konstantin G Kousoulas*

Abstract
Background: Herpes simplex virus type-1 (HSV-1) enters into cells via membrane fusion of the viral envelope with
plasma or endosomal membranes mediated by viral glycoproteins. HSV-1 virions attach to cell surfaces by binding
of viral glycoproteins gC, gD and gB to specific cellular receptors. Here we show that the human ocular and highly
neurovirulent HSV-1 strain McKrae enters substantially more efficiently into cells via the gB-specific human paired
immunoglobulin-like type-2 receptor-a (hPILR-a). Comparison of the predicted amino acid sequences between
HSV-1(F) and McKrae strains indicates that amino acid changes within gB, gC, gH and gL may cause increased
entry via the hPILR- a receptor.
Results: HSV-1 (McKrae) entered substantially more efficiently than viral strain F in Chinese hamster ovary (CHO) cells
expressing hPIRL-a but not within CHO-human nectin-1, -(CHO-hNectin-1), CHO-human HVEM (CHO-hHVEM) or Vero
cells. The McKrae genes encoding viral glycoproteins gB, gC, gD, gH, gL, gK and the membrane protein UL20 were
sequenced and their predicted amino acid (aa) sequences were compared with virulent strains F, H129, and the
attenuated laboratory strain KOS. Most aa differences between McKrae and F were located at their gB amino termini
known to bind with the PILRa receptor. These aa changes included a C10R change, also seen in the neurovirulent strain
ANG, as well as redistribution and increase of proline residues. Comparison of gC aa sequences revealed multiple aa
changes including an L132P change within the 129-247 aa region known to bind to heparan sulfate (HS) receptors.
Two aa changes were located within the H1 domain of gH that binds gL. Multiple aa changes were located within the
McKrae gL sequence, which were preserved in the H129 isolate, but differed for the F strain. Viral glycoproteins gD and
gK and the membrane protein UL20 were conserved between McKrae and F strains.
Conclusions: The results indicate that the observed entry phenotype of the McKrae strain is most likely due to a
combination of increased binding to heparan sulfate receptors and enhanced virus entry via gB-mediated fusion of
the viral envelope with plasma membranes.

Introduction
Herpes simplex type 1 (HSV-1), Herpes simplex type 2
(HSV-2) and Varicella-zoster virus (VZV) are human
neurotropic viruses that belong to the Alphaherpesvirinaesubfamily and are a major cause of worldwide morbidity [1-4]. Neurovirulence, establishment of latency in
sensory neurons and intermittent reactivation are some
* Correspondence: vchoul1@lsu.edu; vtgusk@lsu.edu
Division of Biotechnology and Molecular Medicine and Department of
Pathobiological Sciences, Louisiana State University School of Veterinary
Medicine, Baton Rouge, LA 70803, USA

of the unique properties of these viruses [5,6]. Reactivation of latent virus from trigeminal ganglia can lead to
recurrent ocular infections and is a leading cause of
blindness in developed countries [7,8]. In very rare cases
HSV-1 can spread spontaneously to the brain, causing
life threatening herpes encephalitis [3].
Herpes virus initiates infection by binding to heparan
sulfate (HS) moieties on cell surfaces using viral glycoproteins gC and gB [9]. Moreover, viral glycoprotein D
(gD) binds to different cellular receptors including the
herpesvirus entry mediator (HVEM, or HveA), nectin-1
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(HveC), or 3-O-sulfated HS [10-12]. Apparently, gB can
also bind to additional receptors including the paired
immunoglobulin-like type 2 receptor alpha (PILRa),
non-muscle myosin heavy chain IIA (NMHC-IIA), and
myelin-associated glycoprotein (MAG) that function in
virion attachment and virus entry [13-15]. HSV-1 enters
into epithelial and neuronal cells via a pH-independent
fusion of the viral envelope with plasma membranes,
while it can enter into a wide range of non-neuronal
cells via either pH-independent or pH-dependent endocytosis. Binding of gD and gB to their cognate receptors
is thought to trigger sequential conformational changes
in gH/gL and gB causing gB-mediated fusion of the viral
envelope with cellular membranes during virus entry, as
well as fusion among cellular membranes [16-18].
HSV-1 clinical isolates, such as the McKrae and H129
strains, are known to be highly virulent in rodents and
rabbits in comparison to other laboratory strains such
as KOS [19-21]. Several viral proteins and glycoproteins
contribute to neurovirulence and latency in vivo, however their mode of action is not well elucidated [22-30].
HSV-1 gK is known to be involved in neurovirulence
[30-34], and is a structural component of the virion particle functioning in virus entry into epithelial cells
[35,36], cytoplasmic virion envelopment, virion egress
and virus-induced cell fusion [37-39]. Recently, we
showed that that HSV-1 gK and UL20 physically bind to
gB and gH and modulate gB-mediated membrane fusion
[40,41]. Also, we reported that gK is essential for virus
spread in the cornea of mice, neuroinvasiveness and
establishment of latency into ganglionic neurons [34].
In this manuscript, we compared the relative efficiency
of virus entry between HSV-1 McKrae and F strains and
found that McKrae entered substantially more efficiently
into Chinese hamster ovary (CHO) cells expressing the
hPIRLa. We sequenced all viral genes encoding viral
glycoproteins involved in entry and cell-to-cell fusion
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and identified aa differences between McKrae and F
strains that may cause the observed enhanced entry of
McKrae over other viral strains.

Results
Both McKrae and F viruses appeared to enter with similar efficiency into Vero and CHO cells expressing either
nectin-1 or HVEM (Figure 1: A, C, D, respectively). In
contrast, F entered into CHO cells expressing PILRa
substantially less efficiently than McKrae (Figure 1: B).
Comparison of McKrae, F, KOS and H129 gB aa
sequences (Figure 2) revealed that most of the aa differences between the four strains were located within the
N-terminal 80 aa of gB. Amino acid comparison of four
strains revealed that KOS had a number of aa that differed from the other HSV-1 strains. McKrae gB had a
unique aa (A28V) within its predicted signal sequence
(Figure 2). Comparison of F and McKrae gB sequences
showed the following aa changes: C10R, A28V, P61A,
A62P, T67P, N77P, and P79K (Table 1).
Comparison of the aa sequence of gC of HSV-1
McKrae, F, KOS and H129 revealed that aa variations
between the four strains were distributed throughout
the molecule (Figure 3). Although McKrae and KOS
were more similar to each other, McKrae differed from
all three strains at aa positions 289 (A289D) and 299
(F299L). Specifically, there were 20 nucleotide differences between gC of F and McKrae strains. Out of 20
nucleotide differences only 8 resulted in the aa changes
V16L, Q75K, D116G, L132P, A289D, F299L, H306R,
R421H (Table 2). Nucleotide comparison between gD of
HSV-1 F and McKrae strain revealed no aa differences
between the McKrae and F strains (data not shown).
Comparison of the McKrae, F and H129 gH aa
sequences revealed that these proteins were highly conserved (Figure 4). There were only three aa differences
in the H1 domain of gH and two aa differences within

Figure 1 Comparison of HSV-1(F) and McKrae entry efficiencies. (A) Entry into Vero cells. (B) Entry into CHO-hPILRa. (C) Entry human CHOnectin-1. (D) Entry into CHO-hHVEM (D). All cells were infected with HSV-1(F) or McKrae at an MOI of 1. At 12 h post-infection, the cells were
stained with anti-ICP4 antibody and analyzed by flow cytometry to determine the percentage of infected cells.
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Figure 2 Alignment of the predicted glycoprotein B (gB) amino acid sequences specified by HSV-1 strains McKrae, H129, F and KOS.
Amino acids that match the McKrae sequence are represented by dots. Amino acid changes that are different with respect to the HSV-1 McKrae
strain are shown. The region of gB (aa 1-640), which contains aa substitutions is shown.

the C terminal H3 domain of gH. There were two
unique aa substitutions (S670N and C720R) in McKrae
gH that were not present in either strain F or H129.
Moreover, HSV-1(F) and McKrae strains differed by
four aa in gH (Y147H, V150A, N670S, and R720C)
(Table 3). Amino acid alignment of gL encoded by
McKrae, F, H129 and KOS revealed a number of aa differences that were spread across the entire molecule
(Figure 5). The aa sequence of strain McKrae was similar to strain H129 except at aa residues 171,181 and
212. Comparison between nucleotide sequence of gL of
HSV-1 F and McKrae strain revealed 19 nucleotide differences, ten of which coded for different aa (S22P,
K90R, V100G, N115D, P168L, G171R, P181S, P196S,
L202S, A212T) (Table 4). Seven of these aa changes
were conserved in the H129 strain (P22, R90, G100,
D115, L168, S196, S202) (Table 4). F and McKrae gK
sequences were absolutely conserved despite four
nucleotide changes within their genes. Similarly, there
were four nucleotide changes between the UL20 gene of
HSV-1 F and McKrae strains without causing any aa
changes.

Discussion
HSV-1 utilizes multiple receptors to attach and enter
into a variety of cells including neurons. Recently, it was
shown that gB binds to cellular receptors that are
required for gB-mediated membrane fusion during virus

entry and virus-induced cell fusion. We show here that
the HSV-1 McKrae strain utilizes the gB receptor PIRLa
more efficienty than HSV-1(F). DNA sequencing of all
viral glycoprotein genes involved in membrane fusion
indicates that there are a number of aa differences
between HSV-1(F) and McKrae in gB, gH and gL that
may affect PIRLa- mediated virus entry.
Initial entry experiments revealed that PIRL-a did not
function as efficiently in facilitating virion entry in comparison to the gD receptors nectin-1 and HVEM when
strains HSV-1(F) and KOS were used (not shown).
Recently, we cloned the HSV-1(McKrae) strain as a bacterial articifical chromosome (bac) that has enabled us
to rapidly produce mutant viruses, as we have previously
done with HSV-1(F) bac [42,43]. We have found that
this viral strain efficiently enters into a variety of cells
including CHO cells constitutively expressing PIRLa.
PIRLa binds gB and membrane fusion can be affected
by interactions of gB with viral glycoproteins gD, gH/gL
and gK/UL20 [18,40,41]. Therefore, we compared the
predicted aa sequences between F and McKrae strains
and found a number of aa that could contribute to the
observed increased efficiency of entry of McKrae over F
and other strains. Of particular importance were aa
changes between F and McKrae located within the
amino terminus of gB, known to bind to PIRLa and gK
[41,44]. Specifically, gB binds to PIRLa via O-linked glycans located at aa positions 53 and 480 [44]. However,
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Table 1 HSV-1 (F) and McKrae gB Nucleotide and Amino
acid Differences
Base#
28

F
T

McKrae

Amino acid #

Amino acid
change

C

10

Cys ® Arg

28

Ala ® Val

Table 2 HSV-1 (F) and McKrae gC Nucleotide and Amino
acid Differences
Base#

F

McKrae

Amino acid #

Amino acid change

46

G

T

16

Val ® Leu

177

G

A

223
279

C
A

A
G

75

Gln ® Lys

347

A

G

116

Asp ® Gly

393

T

C

394

T

C

132

Leu ® Pro

395

T

C

594

A

G

619

G

A

C
C

T
A

289

Ala ® Asp

T

G

299

Phe ® Leu

306

His ® Arg

421

Arg ® His

83

C

T

150

A

C

181
184

C
G

G
C

61
62

Pro ® Ala
Ala ® Pro

199

A

C

67

Thr ® pro

229

A

C

77

Asn ® Pro

230

A

C

77

Asn ® Pro

235

C

A

79

Pro ® Lys

236

C

A

79

Pro ® Lys

966

T

C

636
866

1,513
1,899

C
C

A
T

897
917

A

G

1,932

C

T

981

A

C

2,073

C

A

1,071

G

A

2,196

C

T

1,254

G

A

2,373

T

C

1,262

G

A

1,365
1,485

G
A

A
G

gB binding to PIRLa is also dependent on the conformation of the amino terminus of gB, since aa insertions
in gB could reduce this binding [45]. Insertional mutagenesis has revealed that the structure and function of
gB is not particularly flexible in tolerating aa insertions
[46]. The McKrae gB contains additional proline residues at aa positions 67 and 77, while other proline residues have been re-arranged. Specifically, the F gB has a

proline at aa 61, which is an alanine for the McKrae
strain, but the McKrae gB contains a proline at aa 62
instead of alanine. The structure of the amino terminus
of gB is not known, although the x-ray structure of gB
(aa 111-726) was obtained [17]. The additional proline

Figure 3 Alignment of the predicted glycoprotein C (gC) amino acid sequences specified by HSV-1 strains McKrae, H129, F and KOS.
Amino acids that match the McKrae sequence are represented by dots. Amino acid changes that are different with respect to the HSV-1 McKrae
strain are shown.
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Figure 4 Alignment of the predicted glycoprotein H (gH) amino acid sequences specified by HSV-1 strains McKrae, H129 and F. Amino
acids that match the McKrae sequence are represented by dots. Amino acid changes that are different with respect to the HSV-1 McKrae strain
are shown.

residues suggest that the amino terminus of gB assumes
a conformation that may affect binding to PIRLa
[44,47-49]. In addition, this altered conformation of gB
may affect interactions with gK, which binds to the
amino terminus of gB and regulates gB-mediated membrane fusion [41]. Interestingly, six aa changes seen in
McKrae versus F gB were conserved in the gB specified
by the neurovirulent strain ANG [22] suggesting that
these aa may contribute to neurovirulence.
Viral glycoproteins gD and gH have been shown to
bind gB and modulate its ability to cause membrane
fusion [18]. Therefore, mutations within the extracellular
portions of gD and gH, as well as gL may affect the ability
Table 3 HSV-1 (F) and McKrae gH Nucleotide and Amino
acid Differences
Base#

F

McKrae

Amino acid #

439

T

C

147

Tyr ® His

449

T

C

150

Val ® Ala

558

A

G

1,596
1,650

G
A

T
C
670

Asn ® Ser

720

Arg ® Cys

1,899

C

T

2,009

A

G

2,067

C

G

2,158

C

T

2,217

A

G

2,301

G

A

Amino acid change

of gB to utilize the PIRL-a receptor. In addition, since gH
forms a functional heterodimer with gL [50], it is possible
that the observed aa differences between McKrae and F
within gH domain H1 may affect interaction with gL,
known to bind exclusively to this domain [51]. The carboxyl terminus of gH has been shown to be important
for virus-induced cell fusion [43]. Therefore, the observed
aa changes N670S and R720C may alter virus entry
kinetics. Multiple aa changes in gL between McKrae and
F (S22P, K90R, V100G, N115D) are within the gL domain
known to interact with gH and may affect gH/gL cellsurface expression, cell fusion and virus entry.
Positively charged aa residues are known to be critical
for interaction with negatively charged sulfate/carboxylate groups of the HS chain [52]. Moreover, basic aa
residues are known to be critical for HS-binding activity
[53]. Therefore, the gC Q75K and H306R aa changes in
McKrae compared to F may cause increased HS binding.
Previous studies have delineated the HS-binding domain
that interacts with gC amino terminal residues to be
located between aa 33 and 123 [54], and between 129
and 247 [55]. Therefore amino acid changes in McKrae
gC (aa 75, 116 and 132) may result in increased initial
binding of McKrae gC.
The PILR alpha gene is expressed on cells of the
immune system (monocytes, dendritic cells, NK cells, B
cells, macrophages, neutrophils, eosinophils, mast cells),
as well as neurons [13,56]. Moreover, HSV-1 enters into
corneal epithelial cells (HCE) via the nectin1, HVEM
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Figure 5 Alignment of the predicted glycoprotein L (gL) amino acid sequences specified by HSV-1 strains McKrae, H129, F and KOS.
Amino acids that match the McKrae sequence are represented by dots. Amino acid changes that are different with respect to the HSV-1 McKrae
strain are shown.

and PILRa receptors [57]. Additional experiments are
needed to determine the biological and pathogenetic
implications of increased utilization of the PIRLa receptor by the HSV-1(McKrae). The availability of the
McKrae strain as a bacterial artificial chromosome will
enable the rapid construction of mutant viruses that
could be used to elucidate the role of each viral glycoprotein in PIRLa mediated virion entry.

Materials and methods
Cells and Viruses

The clinical ocular isolate and neuroinvasive strain of
HSV-1 (the parental wild-type), McKrae strain, was
obtained from Dr. J. M. Hill (Louisiana State University
Health Sciences Center, New Orleans, LA, USA). African green monkey kidney (Vero) cells were obtained
from the American Type Culture Collection (Rockville,
Table 4 HSV-1 (F) and McKrae gL Nucleotide and Amino
acid Differences
Base#

F

McKrae

21

C

T

Amino acid #

Amino acid change

22

Ser ® Pro

90

Lys ® Arg

100

Val ® Gly

64

T

C

165

T

C

261
269

T
A

C
G

273

A

G

294

A

G

299

T

G

327

C

T

333

A

G

343

A

G

115

Asn ® Asp

489
503

A
C

C
T

168

Pro ® Leu

511

G

A

171

Gly ® Arg

541

C

T

181

Pro ® Ser

586

C

T

196

Pro ® Ser

605

T

C

202

Leu ® Ser

634

G

A

212

Ala ® Thr

660

C

T

MD, USA) and grown and propagated in Dulbecco’s
modified Eagle Medium (DMEM) supplemented with
7% fetal bovine serum (FBS) and antibiotics. The HSV-1
McKrae strain was maintained as a low passage stock
on Vero cells. CHO-neo cells and CHO-nectin 1 were a
kind gift from Dr. Yasushi Kawaguchi, (The University
of Tokyo, Tokyo, Japan) and were propagated in Ham’s
F12 medium supplemented with 10% fetal calf serum
(FCS) and 250 μg G418/ml. The CHO-hPLIRa cells
were obtained from Dr. Hishashi Arase, (Osaka University, Osaka Japan), were grown in Ham’s F12 medium
supplemented with 10% fetal calf serum (FCS) and puromycin, 1 ug/ml. The human CHO-HVEM was created
in our laboratory using PiggyBac Transposon system
(System Biosciences). HVEM gene was cloned into
PB514BL-1 PiggyBac Dual Promoter Vector and CHO
cells expressing HVEM were selected using puromycin,
12 ug/ml. All cells were cultured in non-selective medium prior to use in infectivity assays.
Viral DNA extraction and DNA sequencing

Viral DNA was isolated from infected Vero cells as
described earlier for tissue samples [34]. Briefly, confluent monolayers of Vero cells were infected at a multiplicity of infection of 2 and harvested by scraping at 24
hour post-infection. Cell pellets were rinsed with PBS
and viral DNA was extracted using the DNAeasy Blood
and Tissue Kit according to manufacturer’s instruction
(Qiagen, Valencia, CA, USA).
Purified McKrae DNA and Fail Safe DNA polymerase
(Epicentre Biotechnologies, Madison, WI) were used for
PCR. Due to the high GC content of the genomic DNA,
PCR was performed using a series of primers which generated overlapping products encompassing the entire gene
to be sequenced. PCR products were column-purified
(Zymo Research Corp., Orange, CA) and sequencing reactions were prepared using the Big Dye Terminator v3.1
Cycle sequencing Kit (Life Technologies). DNA sequencing was performed in both directions by a primer walking
strategy for each gene using an automated DNA sequencer
(3130 Genetic Analyzer, Applied Biosystems). The list of
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all synthetic oligo-nucleotides used for amplification of the
McKrae genes and sequencing is shown in the Additional
file 1, Table 1.
Sequence assembly and nucleotide and amino acid
alignments

The Sequencher (4.10.1) software package was used to
assemble the overlapping fragments using default parameters. Sequence assembly was performed using the
HSV-1 (F) strain as the reference sequence (Gene Bank:
GU734771.1). Nucleotide sequences of the following
McKrae genes: gB, gC, gD, gH, gL, gK and UL20 were
submitted to GenBank (accession numbers: JQ320080.1,
JQ359758.1, JQ320083.1, JQ320081.1, JQ359759.1,
JQ320082.1, JQ320079.1).
The CLC sequence Viewer version 6 software was
used to align the aa sequences of H129 (GenBank:
GU734772.1), F (GenBank: GU734771.1) and KOS strain
(gB:AAG34116.1; gC: AAA45779.1; gL: AAA99790.1)
against the derived McKrae sequences. Alignment was
performed using the default parameters of the Clustal
W alignment program (CLC sequence viewer software).
To determine nucleotide and aa sequence variation
between the McKrae and F strains, the sequences were
aligned by the MegAlign program in the DNASTAR
software package (Lasergene). The differences in nucleotides and aa in the coding region of each sequenced
gene were tabulated in Tables 1, 2, 3 and 4.
Virus entry assays

Confluent monolayers of CHO-neo, CHO-hHVEM,
CHO-hPILRa, CHO-human nectin-1 and Vero cells
were infected with HSV-1 strains (McKrae and F) at a
multiplicity of infection of 1 for 1 hr at 34°C. The virus
inoculum was subsequently removed, and the cultures
were shifted to 37°C. Twelve hours post-infection (hpi),
the cells were fixed and stained with anti-ICP4 antibody
(Virusys, Inc., Taneytown, MD) and Alexa Fluor 647
goat anti-mouse IgG1(Life Technologies, Grand Island,
NY). The relative efficiency of virus entry was calculated
by flow cytometry as the percentage of cells expressing
ICP4 normalized to the CHO-neo entry values. Mean
values and standard deviations of three independent
experiments were calculated.

Additional material
Additional file 1: Table S1. Sequencing and PCR primers.

Abbreviations
HVEM, Herpes virus entry mediator; CHO, Chinese hamster ovary; hPILRα,
Human paired immunoglobulin-like type 2 receptor α
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